Response and Resistance to NF-κB Inhibitors in Mouse Models of Lung Adenocarcinoma

Lung adenocarcinoma is a leading cause of cancer death worldwide. We recently showed that genetic inhibition of the NF-κB pathway affects both the initiation and the maintenance of lung cancer, identifying this pathway as a promising therapeutic target. In this investigation, we tested the efficacy...

Full description

Bibliographic Details
Main Authors: Xue, Wen (Contributor), Meylan, Etienne (Contributor), Oliver, Trudy (Contributor), Feldser, David M. (Contributor), Winslow, Monte Meier (Contributor), Bronson, Roderick T. (Contributor), Jacks, Tyler E. (Contributor)
Other Authors: Massachusetts Institute of Technology. Department of Biology (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: American Association for Cancer Research, 2011-10-24T14:38:14Z.
Subjects:
Online Access:Get fulltext